Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?

Breitkopf-Heinlein, Katja; Martinez-Chantar, Maria Luz

Breitkopf-Heinlein, Katja; Martinez-Chantar, Maria Luz.

Affiliation

Breitkopf-Heinlein K; Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Baden-Württemberg, Germany katja.breitkopf@medma.uni-heidelberg.de.
Martinez-Chantar ML; Liver Disease Lab, Center for Cooperative Research in Biosciences, Derio, Spain.

Gut ; 73(9): 1411-1413, 2024 Aug 08.

Article in En | MEDLINE | ID: mdl-38684236

Subject(s)

Hepatic Stellate Cells; Liver Cirrhosis; Animals; Humans; Hepatic Stellate Cells/drug effects; Hepatic Stellate Cells/metabolism; Liver Cirrhosis/drug therapy; Liver Cirrhosis/pathology

Key words

CELL BIOLOGY; CHRONIC LIVER DISEASE

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatic Stellate Cells / Liver Cirrhosis Limits: Animals / Humans Language: En Journal: Gut Year: 2024 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google